María Dolores del Toro López

Dr. María Dolores del Toro López

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
BGBelén Gutiérrez-Gutiérrez
Belén Gutiérrez-Gutiérrez
ESElena Salamanca
Elena Salamanca
MCMarina de Cueto
Marina de Cueto
PHPo-Ren Hsueh
Po-Ren Hsueh
PVPierluigi Viale
Pierluigi Viale
EJE Jové
E Jové

31 August 2012 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
Jaime Lora-TamayoJaime Lora-Tamayo
Jaime Lora-Tamayo
Óscar MurilloÓscar Murillo
Óscar Murillo
JIJosé Antonio Iribarren
José Antonio Iribarren
ASAlex Soriano
Alex Soriano
MSMar Sánchez-Somolinos
Mar Sánchez-Somolinos
FPFerran Pérez
Ferran Pérez
Background. Several series predicting the prognosis of staphylococcal prosthetic joint infection (PJI) managed with debridement, antibiotics, and implant retention (DAIR) have been published, but some of their conclusions are controversial. At present, little is known regarding the efficacy of the different antibiotics that are used or their ability to eliminate methicillin-resistant S. aureus (MRSA) infection. Methods. This was a retrospective, multicenter, observational study of cases of PJI by S. aureus that were managed with DAIR (2003–2010). Cases were classified as failures when infection persistence/relapse, death, need for salvage therapy, or prosthesis removal occurred. The parameters that predicted failure were analyzed with logistic and Cox regression. Results. Out of 345 episodes (41% men, 73 years), 81 episodes were caused by MRSA. Fifty-two were hematogenous, with poorer prognoses, and 88% were caused by methicillin-susceptible S. aureus (MSSA). Antibiotics were used for a median of 93 days, with similar use of rifampin-based combinations in MSSA- and MRSA-PJI. Failure occurred in 45% of episodes, often early after debridement. The median survival time was 1257 days. There were no overall prognostic differences between MSSA- and MRSA-PJI, but there was a higher incidence of MRSA-PJI treatment failure during the period of treatment (HR 2.34), while there was a higher incidence of MSSA-PJI treatment failure after therapy. Rifampin-based combinations exhibited an independent protective effect. Other independent predictors of outcome were polymicrobial, inflammatory, and bacteremic infections requiring more than 1 debridement, immunosuppressive therapy, and the exchange of removable components of the prosthesis. Conclusions. This is the largest series of PJI by S. aureus managed with DAIR reported to date. The success rate was 55%. The use of rifampin may have contributed to homogenizing MSSA and MRSA prognoses, although the specific rifampin combinations may have had different efficacies.

1 August 2016 in Clinical Microbiology and Infection
Verified
Journal Article
Closed access
Natividad BenitoNatividad Benito
Natividad Benito
MFM. Franco
M. Franco
ARA. Ribera
A. Ribera
ASAlex Soriano
Alex Soriano
Dolors Rodriguez-PardoDolors Rodriguez-Pardo
Dolors Rodriguez-Pardo
APA. Puente
A. Puente

8 August 2013 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
LLLuis Eduardo López-Cortés
Luis Eduardo López-Cortés
MLMaría Dolores del Toro López
María Dolores del Toro López
JGJuan Gálvez-Acebal
Juan Gálvez-Acebal
EBElena Bereciartua-Bastarrica
Elena Bereciartua-Bastarrica
MFMaría Carmen Fariñas
María Carmen Fariñas
VMVictoria Manzano-Gamero
Victoria Manzano-Gamero
Background. Staphylococcus aureus bacteremia (SAB) is associated with significant morbidity and mortality. Several aspects of clinical management have been shown to have significant impact on prognosis. The objective of the study was to identify evidence-based quality-of-care indicators (QCIs) for the management of SAB, and to evaluate the impact of a QCI-based bundle on the management and prognosis of SAB. Methods. A systematic review of the literature to identify QCIs in the management of SAB was performed. Then, the impact of a bundle including selected QCIs was evaluated in a quasi-experimental study in 12 tertiary Spanish hospitals. The main and secondary outcome variables were adherence to QCIs and mortality. Specific structured individualized written recommendations on 6 selected evidence-based QCIs for the management of SAB were provided. Results. A total of 287 and 221 patients were included in the preintervention and intervention periods, respectively. After controlling for potential confounders, the intervention was independently associated with improved adherence to follow-up blood cultures (odds ratio [OR], 2.83; 95% confidence interval [CI], 1.78–4.49), early source control (OR, 4.56; 95% CI, 2.12–9.79), early intravenous cloxacillin for methicillin-susceptible isolates (OR, 1.79; 95% CI, 1.15–2.78), and appropriate duration of therapy (OR, 2.13; 95% CI, 1.24–3.64). The intervention was independently associated with a decrease in 14-day and 30-day mortality (OR, 0.47; 95% CI, .26–.85 and OR, 0.56; 95% CI, .34–.93, respectively). Conclusions. A bundle orientated to improving adherence to evidence-based QCIs improved the management of patients with SAB and was associated with reduced mortality.

1 November 2014 in Clinical Microbiology and Infection
Verified
Journal Article
Open access
PDF file
Dolors Rodriguez-PardoDolors Rodriguez-Pardo
Dolors Rodriguez-Pardo
CPC. Pigrau
C. Pigrau
JLJ. Lora-Tamayo
J. Lora-Tamayo
ASAlex Soriano
Alex Soriano
MLMaría Dolores del Toro López
María Dolores del Toro López
JAJ. Ariza
J. Ariza
Prosthetic joint infection (PJI) is an uncommon complication (1–2%) of joint replacement surgery associated with high morbidity and medical expenditure [ 1 x 1 Huo, MH, Gilbert, NF, and Parvizi, J. What's new in total hip arthroplasty. J Bone Joint Surg Am. 2007; 89: 1874–1885 Crossref | PubMed | Scopus (22) | Google Scholar See all References , 2 x 2 Zimmerli, W, Trampuz, A, and Ochsner, PE. Prosthetic‐joint infections. N Engl J Med. 2004; 351: 1645–1654 Crossref | PubMed | Scopus (627) | Google Scholar See all References ]. The most frequently isolated microorganisms are gram-positive cocci. However, gram-negative bacteria (GNB) constitute 10–23% of all episodes, and these infections are often acute [ 3 x 3 Hsieh, PH, Lee, MS, Hsu, KY, Chang, YH, Shih, HN, and Ueng, SW. Gram‐negative prosthetic joint infections: risk factors and outcome of treatment. Clin Infect Dis. 2009; 49: 1036–1043 Crossref | PubMed | Scopus (92) | Google Scholar See all References , 4 x 4 Tattevin, P, Cremieux, AC, Pottier, P, Huten, D, and Carbon, C. Prosthetic joint infection: when can prosthesis salvage be considered?. Clin Infect Dis. 1999; 29: 292–295 Crossref | PubMed | Scopus (172) | Google Scholar See all References , 5 x 5 Zimmerli, W and Ochsner, PE. Management of infection associated with prosthetic joints. Infection. 2003; 31: 99–108 Crossref | PubMed | Scopus (237) | Google Scholar See all References ].

1 November 2011 in Clinical Microbiology and Infection
Verified
Journal Article
Open access
PDF file
JCJ. Cobo
J. Cobo
LML. Garcia San Miguel
L. Garcia San Miguel
GEG. Euba
G. Euba
Dolors Rodriguez-PardoDolors Rodriguez-Pardo
Dolors Rodriguez-Pardo
Juan M. García-LechuzJuan M. García-Lechuz
Juan M. García-Lechuz
JAJ. Ariza
J. Ariza
Recent expert reviews recommend a conservative surgical strategy – debridement and irrigation, antibiotics and implant retention (DAIR) – for most early post-surgical prosthetic joint infections (PJI). However, differences exist in published series regarding success rates with DAIR, and the size of most series is small. In this prospective multicenter cohort study of early PJI managed by DAIR, factors associated with failure of the DAIR were analyzed. Out of 139 early PJI, 117 cases managed with DAIR were studied For 67 patients (57.3%), infection was cured and the implant was salvaged with definite antimicrobial therapy. In 35 (29.9%) DAIR failed and removal of the prosthesis was necessary during follow-up. Finally, 15 patients (12.8%) needed chronic suppressive antimicrobial therapy due to suspected or confirmed persistent infection. Infections due to methicillin-resistant S. aureus (72.7% failed; p 0.05) and those treated at one of the hospitals (80.0% failed; p <0.05) had worse outcomes, but only this last variable was associated with treatment failure following multivariate analysis. Seventy-four per cent of patients who were successfully treated by DAIR and only 32.7% of the failures were able to walk without help or with one stick at the last follow-up visit (p <0.05). In conclusion, a substantial proportion of patients with an early PJI may be successfully treated with DAIR and definite antimicrobial therapy. In more than half of these, the infection can be cured. Since identification of factors associated with failure of DAIR is not simple, we recommend offering DAIR to most patients with early PJI.